Content for an orphan disease

For INTERMUNE, we created the complete content for patients and professionals for the new web presence of the Orphan Drug Esbriet® - the first drug for the treatment of the rare disease idiopathic pulmonary fibrosis.


For the first time, patients and professionals can get online information about the only treatment option available for this serious disease.